{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:09:23Z","timestamp":1792069763759,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["202619\/17"],"award-info":[{"award-number":["202619\/17"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["202620\/17"],"award-info":[{"award-number":["202620\/17"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006702","name":"Universidade do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.oooo.2019.02.014","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:10:19Z","timestamp":1551183019000},"page":"504-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association between biomarkers and medication-related osteonecrosis of the jaws: a systematic review"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-394X","authenticated-orcid":false,"given":"Vittorio","family":"Moraschini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Costa Ferreira","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Marcelo","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Diuana","family":"Calasans-Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2019.02.014_bib0001","first-page":"e542","article-title":"Serum levels of RANKL and OPG, and the RANKL\/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: are they useful biomarkers for the advanced stages of osteonecrosis?","volume":"22","author":"Bagan","year":"2017","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.oooo.2019.02.014_bib0002","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.oooo.2019.02.014_bib0003","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jcms.2017.01.013","article-title":"Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ)","volume":"45","author":"Hoefert","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0004","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14740338.2016.1177021","article-title":"Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology","volume":"15","author":"Fusco","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.oooo.2019.02.014_bib0005","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","article-title":"Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis","volume":"99","author":"Wilkinson","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.oooo.2019.02.014_bib0006","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2010.195","article-title":"Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review","volume":"7","author":"Migliorati","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.oooo.2019.02.014_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2019.02.014_bib0008","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bone.2018.05.001","article-title":"Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice","volume":"112","author":"Kuroshima","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.oooo.2019.02.014_bib0010","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcms.2017.05.028","article-title":"What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a systematic review","volume":"45","author":"Aljohani","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0011","first-page":"1793","article-title":"Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease","volume":"33","author":"Sivolella","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.oooo.2019.02.014_bib0012","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.tripleo.2007.12.023","article-title":"Toxic epidermal necrolysis with a rare long-term oral complication requiring surgical intervention","volume":"105","author":"Sedghizadeh","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2019.02.014_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11914-010-0008-1","article-title":"The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy","volume":"8","author":"Kumar","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.oooo.2019.02.014_bib0014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oooo.2019.02.014_bib0015","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oooo.2019.02.014_bib0016","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tripleo.2008.01.033","article-title":"Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws","volume":"106","author":"Lehrer","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2019.02.014_bib0018","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","article-title":"Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene","volume":"67","author":"Lehrer","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0019","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.joms.2009.04.067","article-title":"Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Kwon","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0020","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.joms.2010.05.043","article-title":"Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates","volume":"68","author":"Lazarovici","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ID.0b013e3181cec8bc","article-title":"CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: A prospective clinical study","volume":"19","author":"Lee","year":"2010","journal-title":"Implant Dent"},{"key":"10.1016\/j.oooo.2019.02.014_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","article-title":"Retrospective study of two biochemical markers for the risk assessment of oralbisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?","volume":"22","author":"Kwon","year":"2011","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.oooo.2019.02.014_bib0023","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.joms.2011.12.028","article-title":"Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases","volume":"70","author":"Morris","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0024","first-page":"819","article-title":"Evaluation of serum biomarkers IL-17 and CTX for BRONJ: a pilot clinical case-control study","volume":"41","author":"Lee","year":"2013","journal-title":"J Calif Dent Assoc"},{"key":"10.1016\/j.oooo.2019.02.014_bib0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijom.2012.12.011","article-title":"The effect of bisphosphonate therapy on neutrophil function: a potential biomarker","volume":"42","author":"Favot","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0026","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bone.2013.08.005","article-title":"Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates","volume":"57","author":"Kim","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.oooo.2019.02.014_bib0027","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jop.12151","article-title":"Oxidative stress in bisphosphonate-related osteonecrosis of the jaws","volume":"43","author":"Bagan","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.oooo.2019.02.014_bib0028","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1158\/1078-0432.CCR-14-0434","article-title":"Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy","volume":"20","author":"Patel","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oooo.2019.02.014_bib0029","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.joms.2015.09.028","article-title":"Serum markers of bone turnover and angiogenesis in patients with bisphosphonate-related osteonecrosis of the jaw after discontinuation of long-term intravenous bisphosphonate therapy","volume":"74","author":"Thumbigere-Math","year":"2016","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0030","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.joms.2015.03.034","article-title":"Salivary biomarkers associated with bone deterioration in patients with medication-related osteonecrosis of the jaws","volume":"73","author":"Kolokythas","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0031","first-page":"45","article-title":"Associations between systemic markers of bone turnover or bone mineral density and anti-resorptive agent-related osteonecrosis of the jaw in patients treated with anti-resorptive agents","volume":"59","author":"Tohashi","year":"2016","journal-title":"Yonago Acta Med"},{"key":"10.1016\/j.oooo.2019.02.014_bib0032","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bjoms.2016.01.009","article-title":"Do measurements of inflammatory mediators in blood predict recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"54","author":"Mucke","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0033","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jbmr.1769","article-title":"Can peripheral blood \u03b3\u03b4 T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy","volume":"28","author":"Kalyan","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.oooo.2019.02.014_bib0034","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.oooo.2019.02.014_bib0035","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0036","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1200\/JCO.2005.06.091","article-title":"Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid","volume":"23","author":"Coleman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oooo.2019.02.014_bib0037","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1359\/jbmr.090203","article-title":"Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw","volume":"24","author":"Baim","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.oooo.2019.02.014_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.oooo.2019.02.014_bib0039","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Cochrane Collaboration","author":"Higgins","year":"2008"},{"key":"10.1016\/j.oooo.2019.02.014_bib0040","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"10.1016\/j.oooo.2019.02.014_bib0041","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.oooo.2019.02.014_bib0042","unstructured":"Grey Literature Report. The New York Academy of Medicine. Available at: www.greylit.org. Accessed February 15, 2018."},{"key":"10.1016\/j.oooo.2019.02.014_bib0043","unstructured":"Open Grey. Available at: www.opengrey.eu. Accessed February 15, 2018."},{"key":"10.1016\/j.oooo.2019.02.014_bib0044","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed March 20, 2018."},{"key":"10.1016\/j.oooo.2019.02.014_bib0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cid.12569","article-title":"Identifying a combined biomarker for bisphosphonate-related osteonecrosis of the jaw","volume":"20","author":"Kim","year":"2018","journal-title":"Clin Implant Dent Relat Res"},{"key":"10.1016\/j.oooo.2019.02.014_bib0046","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00784-015-1706-y","article-title":"Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts","volume":"20","author":"Zafar","year":"2016","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.oooo.2019.02.014_bib0047","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/odi.12513","article-title":"Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw","volume":"22","author":"de Barros Silva","year":"2016","journal-title":"Oral Dis"},{"key":"10.1016\/j.oooo.2019.02.014_bib0048","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.oooo.2012.09.006","article-title":"Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw","volume":"115","author":"Ohbayashi","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2019.02.014_bib0049","first-page":"d51","article-title":"C-terminal cross-linking telopeptide as a serologic marker for bisphosphonate-related osteonecrosis of the jaw: review of 2 cases","volume":"79","author":"Pasoff","year":"2013","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.oooo.2019.02.014_bib0050","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.clinbiochem.2009.02.014","article-title":"The (mis)use of bone resorption markers in the context of bisphosphonate exposure, dental surgery and osteonecrosis of the jaw","volume":"42","author":"Don-Wauchope","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.oooo.2019.02.014_bib0051","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/odi.12204","article-title":"Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw","volume":"21","author":"Thumbigere-Math","year":"2015","journal-title":"Oral Dis"},{"key":"10.1016\/j.oooo.2019.02.014_bib0052","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/SCS.0000000000004224","article-title":"Cross-sectional study of four serological bone turnover markers for the risk assessment of medication-related osteonecrosis of the jaw","volume":"29","author":"Peisker","year":"2018","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0053","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.oooo.2019.02.014_bib0054","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.adaj.2016.02.011","article-title":"Assessing the utility of serum C-telopeptide cross-link of type 1 collagen as a predictor of bisphosphonate-related osteonecrosis of the jaw: a systematic review and meta-analysis","volume":"147","author":"Enciso","year":"2016","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.oooo.2019.02.014_bib0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijom.2016.10.009","article-title":"Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review","volume":"46","author":"Dal Pra","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2019.02.014_bib0056","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/iep.12007","article-title":"Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents","volume":"94","author":"Conte Neto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.oooo.2019.02.014_bib0057","first-page":"222","article-title":"Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants","volume":"24","author":"Doh","year":"2015","journal-title":"Implant Dent"},{"key":"10.1016\/j.oooo.2019.02.014_bib0058","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/JPER.17-0426","article-title":"Periodontal profile class is associated with prevalent diabetes, coronary heart disease, stroke, and systemic markers of C-reactive protein and interleukin-6","volume":"89","author":"Beck","year":"2018","journal-title":"J Periodontol"},{"key":"10.1016\/j.oooo.2019.02.014_bib0059","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pnpbp.2018.04.006","article-title":"Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study","volume":"86","author":"Liemburg","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.oooo.2019.02.014_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(02)00791-3","article-title":"Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting","volume":"31","author":"Qvist","year":"2002","journal-title":"Bone"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440319301476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440319301476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:03:10Z","timestamp":1761948190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440319301476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2212440319301476"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2019.02.014","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between biomarkers and medication-related osteonecrosis of the jaws: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2019.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}